NCT02536183 2023-08-29
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors
Children's National Research Institute
Phase 1 Terminated
Children's National Research Institute
Masonic Cancer Center, University of Minnesota